Immune Cells Use Previously Unknown Pathway to Eliminate AML
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly…
Read the full articleYou might also wanna read
Immune cells use previously unknown pathway to eliminate acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Researchers uncover new T cell attack mechanism against acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effecti

Study reveals why some colorectal cancers respond better to immunotherapy
USC researchers identified a biological pathway that helps activate the immune response against certain types of cancer.
The New Frontier: How Eight Discoveries Are Quietly Transforming Cancer Treatment
New cancer research reveals 16 leukemia subtypes, a solid tumor target for CAR T therapy, and a yeast supplement that boosts immunity — brea
CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors.
Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding th

Comments
Sign in to join the conversation.
No comments yet. Be the first.